Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Rough Cuts is my quick, unvarnished, short and pointed news and commentary sourced from posts I receive every week.

Learn more about whether Globus Medical, Inc. or NovoCure Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Envestnet Portfolio Solutions Inc. lifted its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.0% ...

Globus Medical Trading Up 0.8 % Shares of Globus Medical stock opened at $76.65 on Wednesday. Globus Medical, Inc. has a 52 week low of $49.33 and a 52 week high of $94.93. The stock has a market ...

Unfortunately for shareholders, while the Globus Medical, Inc. (NYSE:GMED) share price is up 80% in the last five years, that's less than the market return. Some buyers are laughing, though ...

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems - ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...